ORIGINAL RESEARCH article

Front. Genet.

Sec. Epigenomics and Epigenetics

Volume 16 - 2025 | doi: 10.3389/fgene.2025.1553410

Epigenetic study of the long-term effects of Gulf War illness

Provisionally accepted
  • 1Genetics, Genomics and Informatics, University of Tennessee Health Science Center (UTHSC), Memphis, TN, United States
  • 2Division of Health Effects Laboratory, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention (CDC), Morgantown, West Virginia, United States
  • 3Preventive Medicine, University of Tennessee Health Science Center (UTHSC), Memphis, TN, United States

The final, formatted version of the article will be published soon.

Gulf War Illness is a chronic multisymptomatic disorder that affects as many as 25-35% of the military personnel who were sent to the Persian Gulf war in 1991. The illness has many debilitating symptoms, including cognitive problems, gastrointestinal symptoms, and musculoskeletal pain. Those so afflicted have been sick for more than 30 years and, therefore, it has become imperative to understand the etiology of Gulf War Illness and then produce treatments to ease the symptoms. We hypothesized that the length of the disease was reflected in epigenetic modification of possibly several genes related to the symptoms. We subjected male and female mice from 11 BXD strains to combined corticosterone and the sarin surrogate, diisopropylfluorophosphate, to emulate the physiological stress of war and the potential exposures to organophosphate pesticides and nerve agent in theater. Three hundred days after treatment, we used Methyl-CpG-binding domain sequencing (MBD-seq) to assay genome-wide methylation. The analysis revealed 20 methylated genes, notably Eif2b5, that regulates myelin production. Loss of myelin with accompanying musculoskeletal pain is a major symptom of Gulf War Illness. Our work demonstrates multiple genes were methylated by exposure to organophosphates and glucocorticoids. These genes point to biochemical mechanisms that may be targets for therapeutic interventionWeek 1, days 1-7, Corticosterone in the drinking water Week 2, day 1 (eight days since corticosterone treatment) i.p. injection of 4 mg/kg DFP Week 3, days 2-7 no corticosterone in the drinking water Weeks 4-12 Corticosterone in drinking water on alternate weeks beginning with week 4 Weeks 13-41 No treatments Week 42 Corticosterone in drinking water Week 43 day 1, euthanize mice, harvest tissue Mouse n=5 per strain, sex, and treatment.

Keywords: MBD-seq, Forward genetcs, QTL (loci of quantitative traits), BXD mice, Neuroinflammation

Received: 30 Dec 2024; Accepted: 08 May 2025.

Copyright: © 2025 Jones, O'Callaghan, Ashbrook, Lu, Prins, ZHAO and Mozhui. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Byron C Jones, Genetics, Genomics and Informatics, University of Tennessee Health Science Center (UTHSC), Memphis, 398163, TN, United States
Khyobeni Mozhui, Preventive Medicine, University of Tennessee Health Science Center (UTHSC), Memphis, 398163, TN, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.